AADI Fundamental Analysis - AADI BIOSCIENCE INC

Fundamental Rating

Overall AADI gets a fundamental rating of 2 out of 10. We evaluated AADI against 558 industry peers in the Biotechnology industry. While AADI seems to be doing ok healthwise, there are quite some concerns on its profitability. AADI is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AADI has reported negative net income.

AADI had a negative operating cash flow in the past year.

In the past 5 years AADI always reported negative net income.

AADI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

AADI has a worse Return On Assets (-71.98%) than 65.44% of its industry peers.

AADI has a Return On Equity (-89.57%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-71.98%
ROE	-89.57%
ROIC	N/A

ROA(3y)-50.74%

ROA(5y)-44.04%

ROE(3y)-60.48%

ROE(5y)-51.04%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AADI has a better Gross Margin (87.39%) than 88.95% of its industry peers.

The Profit Margin and Operating Margin are not available for AADI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	87.39%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AADI does not have a ROIC to compare to the WACC, probably because it is not profitable.

AADI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

AADI has an Altman-Z score of -3.05. This is a bad value and indicates that AADI is not financially healthy and even has some risk of bankruptcy.

AADI has a Altman-Z score (-3.05) which is in line with its industry peers.

AADI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-3.05

ROIC/WACCN/A

WACC10.38%

2.3 Liquidity

AADI has a Current Ratio of 4.89. This indicates that AADI is financially healthy and has no problem in meeting its short term obligations.

AADI has a Current ratio of 4.89. This is comparable to the rest of the industry: AADI outperforms 53.68% of its industry peers.

AADI has a Quick Ratio of 4.54. This indicates that AADI is financially healthy and has no problem in meeting its short term obligations.

AADI has a Quick ratio (4.54) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	4.89
Quick Ratio	4.54

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.69% over the past year.

EPS 1Y (TTM)3.69%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-11.67%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%14.43%

3.2 Future

Based on estimates for the next years, AADI will show a very strong growth in Earnings Per Share. The EPS will grow by 33.74% on average per year.

Based on estimates for the next years, AADI will show a very negative growth in Revenue. The Revenue will decrease by -14.87% on average per year.

EPS Next Y71.14%

EPS Next 2Y23.74%

EPS Next 3Y15.15%

EPS Next 5Y33.74%

Revenue Next Year-46.53%

Revenue Next 2Y-24.02%

Revenue Next 3Y38.79%

Revenue Next 5Y-14.87%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AADI. In the last year negative earnings were reported.

Also next year AADI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as AADI's earnings are expected to grow with 15.15% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y23.74%

EPS Next 3Y15.15%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AADI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AADI BIOSCIENCE INC

NASDAQ:AADI (3/18/2025, 8:20:08 PM)

After market: 2.06 +0.01 (+0.49%)

2.05

-0.05 (-2.38%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)03-18 2025-03-18/amc

Earnings (Next)05-06 2025-05-06/bmo

Inst Owners61.01%

Inst Owner Change129.46%

Ins Owners11.42%

Ins Owner Change38.98%

Market Cap94.85M

Analysts47.5

Price Target3.06 (49.27%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)12.35%

Min EPS beat(2)1.43%

Max EPS beat(2)23.27%

EPS beat(4)3

Avg EPS beat(4)7.54%

Min EPS beat(4)-3.76%

Max EPS beat(4)23.27%

EPS beat(8)6

Avg EPS beat(8)9.48%

EPS beat(12)9

Avg EPS beat(12)8.71%

EPS beat(16)12

Avg EPS beat(16)6.92%

Revenue beat(2)1

Avg Revenue beat(2)2.47%

Min Revenue beat(2)-2.25%

Max Revenue beat(2)7.19%

Revenue beat(4)1

Avg Revenue beat(4)-3.79%

Min Revenue beat(4)-18.68%

Max Revenue beat(4)7.19%

Revenue beat(8)3

Avg Revenue beat(8)-1.69%

Revenue beat(12)7

Avg Revenue beat(12)204.18%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)10.2%

EPS NY rev (1m)8.11%

EPS NY rev (3m)-7.94%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0.68%

Revenue NY rev (1m)0.04%

Revenue NY rev (3m)-1.52%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.78
P/FCF	N/A
P/OCF	N/A
P/B	1.38
P/tB	1.38
EV/EBITDA	N/A

EPS(TTM)-2.35

EYN/A

EPS(NY)-0.68

Fwd EYN/A

FCF(TTM)-1.22

FCFYN/A

OCF(TTM)-1.17

OCFYN/A

SpS0.54

BVpS1.49

TBVpS1.49

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-71.98%
ROE	-89.57%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	87.39%
FCFM	N/A

ROA(3y)-50.74%

ROA(5y)-44.04%

ROE(3y)-60.48%

ROE(5y)-51.04%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.29

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	1232.43%
Cap/Sales	9.09%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.89
Quick Ratio	4.54
Altman-Z	-3.05

F-Score3

WACC10.38%

ROIC/WACCN/A

Cap/Depr(3y)890.25%

Cap/Depr(5y)600.82%

Cap/Sales(3y)7.89%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)3.69%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-11.67%

EPS Next Y71.14%

EPS Next 2Y23.74%

EPS Next 3Y15.15%

EPS Next 5Y33.74%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%14.43%

Revenue Next Year-46.53%

Revenue Next 2Y-24.02%

Revenue Next 3Y38.79%

Revenue Next 5Y-14.87%

EBIT growth 1Y8.77%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-10.26%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-6.68%

OCF growth 3YN/A

OCF growth 5YN/A

AADI BIOSCIENCE INC (AADI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens